Medical University of Vienna: Diabetes Mellitus, Type 2 trials
The registry lists 14 Diabetes Mellitus, Type 2 studies with Medical University of Vienna as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 2 4Phase 3 3Phase 4 3No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Feasibility of Once/Daily Administered GLP/1 Receptoragonist (Lixisenatide) in Combination With Basal InsulinCompletedNCT02168491Phase 3Results posted
- The Impact of Free Fatty Acid (FFA-) Suppression on Myocardial Lipids and Function in Patients With Type 2 DiabetesCompletedNCT01980524Phase 2/3Results posted
- SGLT2 Inhibition in HemodialysisCompletedNCT05179668Phase 2
- Epigenetics Based Diagnosis of Diabetes in Saliva and Blood SamplesStatus unknownNCT04011228
- Study to Develop a Kinetic Model for FDG and Me4FDG in Kidneys of Type 2 Diabetic PatientsStatus unknownNCT03557138Not applicable
- MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal OsteoporosisCompletedNCT03472846Phase 4
- EMPRA (EMPagliflozin and RAs in Kidney Disease)CompletedNCT03078101Phase 2
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.CompletedNCT03007329Phase 4
- Diabetes Mellitus - A Diagnosis Trial by Means of Non Invasive MeasurementsCompletedNCT02028091
- Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor MutationsStatus unknownNCT02023489Not applicable
- Influence of DPP-4 on Inflammatory Parameters in Diabetics: Gender AspectsStatus unknownNCT01162772
- The Influence of Adalimumab on Cardiovascular and Metabolic Risk in PsoriasisStatus unknownNCT01088165Phase 4
- Tele-Diab: Electronic Diary for Patients With Type 2 Diabetes MellitusStatus unknownNCT01058889Phase 3
- Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 DiabetesCompletedNCT00490867Phase 2